Cano Health, Inc. announced that the Company is updating its guidance for full year 2022 provided on November 9, 2021. Consistent with that guidance, the outlook below does not include the impact of additional acquisitions. The updated outlook for full year 2022 is as follows: Total revenue in the range of $2.8 billion to $2.9 billion, an increase from the prior guidance of $2.6 to $2.7 billion.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.27 USD | -12.90% | 0.00% | -95.40% |
May. 21 | Cano Health Reaches Deal With Creditors Committee | DJ |
May. 21 | Fourth Amended Disclosure Statement Approved for Cano Health, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-95.40% | 1.47M | |
-23.70% | 15.44B | |
-1.80% | 11.7B | |
+2.65% | 11.58B | |
+2.48% | 10.12B | |
+26.65% | 8.42B | |
+8.19% | 6.76B | |
+0.18% | 6.08B | |
-3.49% | 4.33B | |
+4.81% | 4.17B |
- Stock Market
- Equities
- JWS Stock
- News Cano Health, Inc.
- Cano Health, Inc. Announces Revenue Guidance for the Year 2022